Severe Thrombocytopenia Associated with Dengue Fever: An Evidence-Based Approach to Management of Thrombocytopenia

  • Das S
  • Abreu C
  • Harris M
  • et al.
N/ACitations
Citations of this article
109Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Dengue is a mosquito-borne viral illness common in tropical and subtropical countries but very rare in the United States. Patients infected with dengue often present with thrombocytopenia. In the setting of dengue, platelet transfusions as a treatment for thrombocytopenia have no clear benefits in reduction of severe bleeding or improvement of the platelet count. Here, we present a case of a traveler infected with dengue virus and discuss the approach to treat thrombocytopenia.

Cite

CITATION STYLE

APA

Das, S., Abreu, C., Harris, M., Shrader, J., & Sarvepalli, S. (2022). Severe Thrombocytopenia Associated with Dengue Fever: An Evidence-Based Approach to Management of Thrombocytopenia. Case Reports in Hematology, 2022, 1–3. https://doi.org/10.1155/2022/3358325

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free